Home » Topics » Regulatory » Patents

Patents
RSS

Celltech reports new PDE IV inhibitors

Jan. 21, 1997

Merck & Co. claims NMDA and AMPA antagonists for neurologic indications

Jan. 21, 1997

New anticonvulsants from Howard University

Jan. 21, 1997

Shaman patents new antifungal agents

Jan. 21, 1997

Mochida claims new formulation for ulinastatin

Jan. 20, 1997

Takeda claims new approach to diabetes Rx

Jan. 20, 1997

New wound-healing agents reported

Jan. 20, 1997

New amylin antagonists from Amylin

Jan. 20, 1997

cAMP PDE inhibitors disclosed by Nippon Kayaku

Jan. 20, 1997

Anti-IL-2 monoclonal antibody described by Ajinomoto

Jan. 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026